|
Venmax Drugs & Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
13.88 Cr.
|
P/BV
|
-21.37
|
Book Value (Rs.)
|
-1.24
|
|
52 Week High/Low (Rs.)
|
31/6
|
FV/ML
|
10/1
|
P/E(X)
|
215.45
|
|
Bookclosure
|
21/09/2024
|
EPS (Rs.)
|
0.12
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 0.09 | 0.23 | 1.85 | -0.16 | -0.27 |
| | | | | | |
| Net CashFlow From Operating Activities | 0.00 | 0.00 | 1.91 | 0.26 | -0.28 |
| Net Cash Used From Financing Activities | 0.00 | 0.00 | -1.98 | -0.19 | 0.28 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.00 | 0.00 | -0.07 | 0.07 | 0.00 |
| Cash And Cash Equivalents Begin of Year | 0.00 | 0.00 | 0.08 | 0.00 | 0.00 |
| Cash And Cash Equivalents End Of Year | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 |
